Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-062738

EVP, Research & CSO sold 3,805 shares at $31.27 ($118,966)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-12-08 Option exercise +3,805 $1.53 $5,822 27,505 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2020-12-08 Sale −3,805 $31.27 $118,966 23,700 D: show line 2 in the form
Open-market sales · 3,805 sh · avg $31.27 · $118,966

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-12-08 Option exercise · Stock Option (Right to Buy) −3,805 439,095 D: show line 3 in the form
Loading xslF345X03/doc4.xml…